Connect with us

Health

Predicting long term outcomes for pre-invasive breast cancer – Health Europa

New research has presented a new and more accurate method of predicting long term outcomes for ductal carcinoma and has confirmed the role of the oestrogen receptor…

Published

on

Article feature image

Oestrogen receptor (ER), a type of protein that is expressed in some breast cancer cells, is routinely tested in invasive breast cancer to predict long-term outcomes and select treatment options, however, its role in ductal carcinoma in situ (DCIS) has been previously unclear. However, this new research confirms the role of ER in predicting long-term outcomes in DCIS.
In the study by Queen Mary University of London, published in Clinical Cancer Research, the authors report a new and more accurate…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending